Literature DB >> 3494958

Antibody to myelin constituents: a possible factor in induction of cell-mediated demyelination.

M E Smith, L J deJong.   

Abstract

Results from this laboratory have demonstrated that 14C-labeled myelin opsonized with antibodies raised to purified CNS myelin in rabbit is phagocytized by cultured macrophages in larger amounts than untreated myelin or myelin opsonized with preimmune serum. The cultured macrophages produced high amounts of radioactive cholesterol ester and triglyceride from the antibody-treated myelin while much less was formed from preimmune serum-treated or untreated myelin. Antiserum to galactocerebroside also greatly enhanced the formation of radioactive cholesterol ester, while that to myelin basic protein as well as to other myelin constituents had little or no effect. Serum from Lewis rats with acute EAE 13-14 days after immunization with whole CNS myelin also stimulated radioactive cholesterol ester formation compared to serum from Freund's adjuvant-injected controls (FAC). Serum from EAE rats as a result of myelin basic protein injection was as active as that from rats with whole myelin injection. No galactocerebroside antibody could be demonstrated in the EAE sera, although a strong immunostaining to myelin basic protein and proteolipid protein was demonstrated. IgG prepared from EAE serum also showed stimulatory effects compared to IgG from FAC serum, but much of the activity was lost, and the possibility that other factors may be involved is discussed. These experiments provide evidence that myelin phagocytosis and digestion by macrophages is enhanced by the presence of antibody to myelin. In EAE this antibody may leak into CNS with the breakdown of the blood-brain barrier.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494958     DOI: 10.1007/BF00979533

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  12 in total

1.  ELECTRON MICROSCOPIC STUDIES ON THE VASCULAR PERMEABILITY AND THE MECHANISM OF DEMYELINATION IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS.

Authors:  P LAMPERT; S CARPENTER
Journal:  J Neuropathol Exp Neurol       Date:  1965-01       Impact factor: 3.685

Review 2.  Pathology of the early lesion in multiple sclerosis.

Authors:  J Prineas
Journal:  Hum Pathol       Date:  1975-09       Impact factor: 3.466

Review 3.  Phagocytosis (first of three parts).

Authors:  T P Stossel
Journal:  N Engl J Med       Date:  1974-03-28       Impact factor: 91.245

4.  Lipid content in brain and spinal cord during experimental allergic encephalomyelitis in rats.

Authors:  B Maggio; F A Cumar; H J Maccioni
Journal:  J Neurochem       Date:  1972-04       Impact factor: 5.372

5.  Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis.

Authors:  L G Epstein; J W Prineas; C S Raine
Journal:  J Neurol Sci       Date:  1983 Oct-Nov       Impact factor: 3.181

Review 6.  The significance of abnormal immune responses in patients with multiple sclerosis.

Authors:  M V Iivanainen
Journal:  J Neuroimmunol       Date:  1981-06       Impact factor: 3.478

7.  Coated pits, coated vesicles, and receptor-mediated endocytosis.

Authors:  J L Goldstein; R G Anderson; M S Brown
Journal:  Nature       Date:  1979-06-21       Impact factor: 49.962

8.  Augmentation of immune-mediated demyelination by lipid haptens.

Authors:  C S Raine; U Traugott; M Farooq; M B Bornstein; W T Norton
Journal:  Lab Invest       Date:  1981-08       Impact factor: 5.662

9.  Opsonization with antimyelin antibody increases the uptake and intracellular metabolism of myelin in inflammatory macrophages.

Authors:  J Trotter; L J DeJong; M E Smith
Journal:  J Neurochem       Date:  1986-09       Impact factor: 5.372

10.  Multiple sclerosis: capping of surface immunoglobulin G on macrophages engaged in myelin breakdown.

Authors:  J W Prineas; J S Graham
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.